ALK Positive seeks to partner with entities who are furthering ALK Lung cancer treatments, as well as medical professionals that play the vital role of first contact for new patients.
As a dynamic, patient-led group, we are raising funds for research to overcome the resistance that develops with targeted therapies, as well as innovations in ALK-positive lung cancer immunotherapy.
In our first year of fundraising, we raised more than $600,000 for immunotherapy research.
Resources for Doctors
Download our brochure for new patients.
It's written by ALK Positive, for ALK-positive lung cancer patients. It helps educate on the basics of, and treatments for, this rare cancer.